We believe that the versions of the precautionary principle mentioned above do not have the usual weaknesses found in other precautionary principles. They are not overly cautious, are different from standard cost-benefit analyses, and, if used correctly, do not lead to confusing results. However, this doesn’t mean these versions are perfect or beyond criticism. They seem reasonable and deserve more examination.
In this section, we want to highlight a general problem when applying the precautionary principle to gene editing for future generations (GGE). It may appear that since GGE has significant and believable risks for future generations, the precautionary principle would advise against it. But this isn't always true; avoiding GGE can also pose serious risks to future generations.
For instance, one possible use of GGE is to eliminate harmful genetic mutations and diseases, which would significantly improve the health of future generations. Not using GGE for this purpose could indirectly harm their health. Additionally, Russell Powell suggests that if we don't pursue GGE, the genetic health of the population will decline over time, causing future generations to rely more on conventional medicine. He argues that modern medicine has reduced the effects of natural selection, allowing harmful genetic mutations to accumulate. Ignoring GGE can lead to two main risks: future generations might have to spend a lot of resources fixing their genetic problems instead of using them for other benefits, and they would be more vulnerable to major problems if medical technologies were no longer available, like during a crisis.
If Powell is right, both pursuing and not pursuing GGE carry significant risks that might trigger the precautionary principles mentioned earlier. Both options have serious worst-case scenarios, threaten public health, and could harm overall well-being for future generations. When looking at it this way, the precautionary principles don't clearly indicate whether GGE should be pursued.
We're not just repeating the common idea that the precautionary principle can be used for and against the same policy. Some versions can indeed be used this way, but those are often criticized for being inconsistent and should be dismissed. Our point is that the risks of pursuing or not pursuing GGE are similar, making it tricky to decide what the precautionary principle would suggest. It's not clear if it would argue against GGE or surprisingly support it.
This confusion partly comes from our limited understanding of the risks associated with GGE. As gene editing technology advances, we may better quantify these risks, which could affect how the precautionary principle is applied. For example, we will better understand the risks of unintended mutations as gene editing becomes more common. Similarly, we will learn more about the genetic risks as we study genetics and how genes relate to traits. We could also better quantify the risks of accumulating harmful mutations due to modern medicine by studying how mutations build up over generations.
So, even though applying the precautionary principle to GGE is challenging now, we might overcome these knowledge gaps in the future. Furthermore, the precautionary principle does offer some clear advice: it suggests favoring certain uses of GGE, especially those focused on maintaining genetic health and reducing long-term risks, over those aimed at changing cosmetic traits or enhancing health beyond a reasonable level. The latter could expose future generations to more long-term harm for the sake of short-term benefits, while the former would not.